These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8847198)

  • 21. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Information-centered family groups for improving compliance in schizophrenic patients].
    Bäuml J; Kissling W; Meurer C; Wais A; Lauter H
    Psychiatr Prax; 1991 Mar; 18(2):48-54. PubMed ID: 1676178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
    Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case study of a schizophrenic patient during social skills training in a forensic psychiatry ward.
    Marshall J; Brand HJ; Hanekom JM
    Psychol Rep; 1993 Feb; 72(1):259-62. PubMed ID: 8451360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quest for well-being: a qualitative study of the experience of taking antipsychotic medication.
    Carrick R; Mitchell A; Powell RA; Lloyd K
    Psychol Psychother; 2004 Mar; 77(Pt 1):19-33. PubMed ID: 15025902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing routine outcome measures in a psychiatric rehabilitation setting.
    Berry K; Poorhady R
    Int J Rehabil Res; 2007 Dec; 30(4):347-9. PubMed ID: 17975457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs and benefits of hospital and day treatment with community care of affective and schizophrenic disorders.
    Wiersma D; Kluiter H; Nienhuis FJ; Rüphan M; Giel R
    Br J Psychiatry Suppl; 1995 Apr; (27):52-9. PubMed ID: 7794594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment adherence as a social ability: a case of patients with schizophrenia].
    Baudrant-Boga M; Holtzmann J; Allenet B; Debeauchamp I; Giraud-Baro E
    J Pharm Belg; 2009 Sep; (3):91-8. PubMed ID: 19873850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [News from the Soteria--a phenomenologically inspired approach to the rehabilitation of social and daily living skills].
    Nischk D; Merz P; Rusch J
    Psychiatr Prax; 2014 Jan; 41(1):45-9. PubMed ID: 23846509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinic discharge of schizophrenic patients: treatment termination or transition? A catamnestic study of community psychiatric management].
    Hell D; Zingg P
    Psychiatr Prax; 1991 Nov; 18(6):202-8. PubMed ID: 1771201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications for the pharmacotherapy of schizophrenia.
    Rep Group Adv Psychiatry; 1992; (134):35-58. PubMed ID: 1348372
    [No Abstract]   [Full Text] [Related]  

  • 34. Medication adherence studies in schizophrenia.
    Hamann J; Pitschel-Walz G; Kissling W
    Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
    [No Abstract]   [Full Text] [Related]  

  • 35. [Self-sufficiency and impaired self-sufficiency in schizophrenic patients].
    Marneros A; Deister A; Rohde A
    Nervenarzt; 1991 Jan; 62(1):41-8. PubMed ID: 2027420
    [No Abstract]   [Full Text] [Related]  

  • 36. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia.
    Kamali M; Kelly L; Gervin M; Browne S; Larkin C; O'Callaghan E
    Psychiatr Serv; 2001 Feb; 52(2):161-3, 166. PubMed ID: 11157110
    [No Abstract]   [Full Text] [Related]  

  • 38. [Psychiatric-anthropologic field work. Sue Estroff: Making it crazy].
    Becker T
    Psychiatr Prax; 1997 Sep; 24(5):251-2. PubMed ID: 9417551
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of standard locked-ward treatment versus open-ward rehabilitation treatment for chronic schizophrenic patients. A one-year controlled trial in Canton.
    Fan Z; Huang J; Wu Q; Jiang S
    Br J Psychiatry Suppl; 1994 Aug; (24):45-51. PubMed ID: 7946231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.